New England Journal of Medicine
February 14, 2019 Vol. 380 No. 7
Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents
Elize M. da Fonseca, Ph.D., Kenneth Shadlen, Ph.D., and Francisco I. Bastos, M.D., Ph.D.
Brazil’s strategy for addressing hepatitis C, which combines evidence-based treatment protocols and innovative initiatives for local production of generic direct-acting antiviral drugs, needs to be considered in light of ongoing conflicts over pharmaceutical patents.